XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in Capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury Stock
Balance, beginning of the period (in shares) at Mar. 31, 2019   141,865,888       (73,167,892)
Balance, beginning of the period at Mar. 31, 2019 $ 1,330,832 $ 14,187 $ 1,406,813 $ 1,669,605 $ 7,801 $ (1,767,574)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   119,186       (255,469)
Employee stock awards, benefit plans and other issuances (11,813) $ 12 2,082     $ (13,907)
Non-cash stock-based compensation (in shares)   58,195        
Non-cash stock-based compensation 31,332 $ 6 31,326      
Restricted stock units vested (in shares)   634,153        
Restricted stock units vested   $ 63 (63)      
Liability-classified restricted stock units vested (in shares)   418,850        
Liability-classified restricted stock units vested 17,704 $ 42 17,662      
Acquisition of treasury stock (in shares)           (2,134,930)
Acquisition of treasury stock (100,473)         $ (100,473)
Acquisition-related replacement stock options 2,300   2,300      
Other comprehensive income (loss):            
Foreign currency translation (1,182)       (1,182)  
Net loss (82,342)     (82,342)    
Balance, end of the period (in shares) at Sep. 30, 2019   143,096,272       (75,558,291)
Balance, end of the period at Sep. 30, 2019 1,186,358 $ 14,310 1,460,120 1,587,263 6,619 $ (1,881,954)
Balance, beginning of the period (in shares) at Jun. 30, 2019   142,451,563       (73,801,287)
Balance, beginning of the period at Jun. 30, 2019 1,272,157 $ 14,245 1,422,879 1,627,465 7,334 $ (1,799,766)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   72,505       (34,274)
Employee stock awards, benefit plans and other issuances (780) $ 8 1,026     $ (1,814)
Non-cash stock-based compensation (in shares)   6,833        
Non-cash stock-based compensation 16,268 $ 1 16,267      
Restricted stock units vested (in shares)   146,521        
Restricted stock units vested   $ 14 (14)      
Liability-classified restricted stock units vested (in shares)   418,850        
Liability-classified restricted stock units vested 17,704 $ 42 17,662      
Acquisition of treasury stock (in shares)           (1,722,730)
Acquisition of treasury stock (80,374)         $ (80,374)
Acquisition-related replacement stock options 2,300   2,300      
Other comprehensive income (loss):            
Foreign currency translation (715)       (715)  
Net loss (40,202)     (40,202)    
Balance, end of the period (in shares) at Sep. 30, 2019   143,096,272       (75,558,291)
Balance, end of the period at Sep. 30, 2019 1,186,358 $ 14,310 1,460,120 1,587,263 6,619 $ (1,881,954)
Balance, beginning of the period (in shares) at Mar. 31, 2020   143,938,753       (78,081,314)
Balance, beginning of the period at Mar. 31, 2020 1,087,512 $ 14,394 1,496,565 1,545,094 5,745 $ (1,974,286)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   194,816       (113,612)
Employee stock awards, benefit plans and other issuances (2,194) $ 19 3,542     $ (5,755)
Non-cash stock-based compensation (in shares)   13,551        
Non-cash stock-based compensation 27,912 $ 1 27,911      
Restricted stock units vested (in shares)   777,618        
Restricted stock units vested   $ 78 (78)      
Liability-classified restricted stock units vested (in shares)   780,400        
Liability-classified restricted stock units vested 24,441 $ 78 24,363      
Acquisition of treasury stock (in shares)           (1,321,666)
Acquisition of treasury stock (42,312)         $ (42,312)
Other comprehensive income (loss):            
Foreign currency translation 1,199       1,199  
Net loss (45,696)     (45,696)    
Balance, end of the period (in shares) at Sep. 30, 2020   145,705,138       (79,516,592)
Balance, end of the period at Sep. 30, 2020 1,050,862 $ 14,570 1,552,303 1,499,398 6,944 $ (2,022,353)
Balance, beginning of the period (in shares) at Jun. 30, 2020   145,248,520       (79,443,337)
Balance, beginning of the period at Jun. 30, 2020 1,058,289 $ 14,525 1,532,481 1,523,366 6,342 $ (2,018,425)
Increase (Decrease) in Stockholders' Equity            
Employee stock awards, benefit plans and other issuances (in shares)   127,026       (73,255)
Employee stock awards, benefit plans and other issuances (1,504) $ 12 2,412     $ (3,928)
Non-cash stock-based compensation (in shares)   5,606        
Non-cash stock-based compensation 17,443   17,443      
Restricted stock units vested (in shares)   323,986        
Restricted stock units vested   $ 33 (33)      
Other comprehensive income (loss):            
Foreign currency translation 602       602  
Net loss (23,968)     (23,968)    
Balance, end of the period (in shares) at Sep. 30, 2020   145,705,138       (79,516,592)
Balance, end of the period at Sep. 30, 2020 $ 1,050,862 $ 14,570 $ 1,552,303 $ 1,499,398 $ 6,944 $ (2,022,353)